Yearly Archives: 2010
The New Economy Magazine A Leading Strategy in a Very Big Place
Allon Therapeutics Inc. has a drug candidate and an innovative strategy that could win one of the biggest contests in today’s pharmaceutical industry – a drug that can halt the progression of Alzheimer’s disease and other progressive neurodegenerative diseases.
Xconomy Allon Treads Into the Great Unknown, Alzheimer’s Disease, With New Kind of Drug
It must take real guts, or maybe hubris, to try to do what Allon Therapeutics is attempting. This Vancouver, BC-based biotech company has designed a drug that is made to work unlike anything else on the market against some of the world’s major neurodegenerative diseases, like Alzheimer’s.
Business in Vancouver Allon Therapeutics’ lead drug to be fast tracked in U.S.
Allon Therapeutics Inc. ( TSX:NPC) sjared were trading above normal volumes Tuesday after the company announced its lead drug candidate will be fast tracked the through the U.S. drug review and approval process.